OBIO

ORCHESTRA BIOMED HOLDINGS, INC.

OBIO · CIK 1814114 · Annual (10-K) · Last 5 years

Financial Trends

Revenue$3M
20202024
Net Income−$61M
20202024
Operating CF−$51M
20202024
Free Cash Flow−$51M
20202024

Income Statement

MetricFY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕
Revenue$0.0B$0.0B———
Cost of Revenue$0.0B$0.0B———
Gross Profit—————
R&D Expense$0.0B$0.0B———
SG&A Expense$0.0B$0.0B———
Operating Income$-0.1B$-0.1B$-0.0B$-0.0B—
Net Income$-0.1B$-0.0B$-0.0B$-0.0B$-0.0B
EPS (Basic)$-1.66$-1.48$-0.17——
EPS (Diluted)$-1.66$-1.48$-0.17——

Balance Sheet

MetricFY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕
Total Assets$0.1B$0.1B$0.1B$0.2B$0.2B
Current Assets$0.1B$0.1B$0.0B$0.0B$0.0B
Cash & Equivalents$0.0B$0.0B$0.0B$0.0B$0.0B
Total Liabilities$0.0B$0.0B$0.0B$0.0B$0.0B
Current Liabilities$0.0B$0.0B$0.0B$0.0B$0.0B
Stockholders' Equity——$-0.0B$-0.0B$0.0B

Cash Flow Statement

MetricFY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕
Operating Cash Flow$-0.1B$-0.0B$-0.0B$-0.0B$-0.0B
Investing Cash Flow$0.0B$0.0B$0.1B$-0.2B$-0.2B
Capital Expenditures$0.0B$0.0B———
Financing Cash Flow$0.0B$0.0B$-0.1B$0.2B$0.2B
← Companies